MinichMacGregor Wealth Management LLC Makes New $297,000 Investment in Axon Enterprise, Inc. (NASDAQ:AXON)

MinichMacGregor Wealth Management LLC bought a new position in shares of Axon Enterprise, Inc. (NASDAQ:AXON) during the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund bought 500 shares of the biotechnology company’s stock, valued at approximately $297,000.

Several other institutional investors and hedge funds have also made changes to their positions in the company. Quent Capital LLC increased its position in Axon Enterprise by 1,875.0% during the third quarter. Quent Capital LLC now owns 79 shares of the biotechnology company’s stock worth $32,000 after buying an additional 75 shares during the period. Prestige Wealth Management Group LLC increased its holdings in shares of Axon Enterprise by 115.8% in the 3rd quarter. Prestige Wealth Management Group LLC now owns 82 shares of the biotechnology company’s stock valued at $33,000 after acquiring an additional 44 shares during the period. Versant Capital Management Inc raised its position in Axon Enterprise by 4,750.0% in the 4th quarter. Versant Capital Management Inc now owns 97 shares of the biotechnology company’s stock valued at $58,000 after purchasing an additional 95 shares during the last quarter. Brooklyn Investment Group acquired a new stake in Axon Enterprise during the 3rd quarter worth $41,000. Finally, Planning Capital Management Corp boosted its stake in Axon Enterprise by 83.3% during the 3rd quarter. Planning Capital Management Corp now owns 121 shares of the biotechnology company’s stock worth $48,000 after purchasing an additional 55 shares during the period. 79.08% of the stock is owned by hedge funds and other institutional investors.

Insider Buying and Selling

In other Axon Enterprise news, insider Jeffrey C. Kunins sold 21,834 shares of the firm’s stock in a transaction on Tuesday, November 12th. The stock was sold at an average price of $593.88, for a total transaction of $12,966,775.92. Following the completion of the transaction, the insider now owns 154,394 shares of the company’s stock, valued at approximately $91,691,508.72. This trade represents a 12.39 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is accessible through this link. Also, Director Michael Garnreiter sold 1,000 shares of the company’s stock in a transaction on Monday, December 16th. The shares were sold at an average price of $639.69, for a total value of $639,690.00. Following the completion of the sale, the director now owns 24,259 shares in the company, valued at $15,518,239.71. This represents a 3.96 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold a total of 50,545 shares of company stock worth $30,721,337 in the last quarter. Company insiders own 6.10% of the company’s stock.

Wall Street Analyst Weigh In

A number of research firms have commented on AXON. Morgan Stanley upgraded shares of Axon Enterprise from an “equal weight” rating to an “overweight” rating and lifted their price objective for the company from $500.00 to $700.00 in a research note on Tuesday, December 3rd. Northland Securities upped their price objective on Axon Enterprise from $365.00 to $550.00 and gave the company an “outperform” rating in a research note on Monday, November 11th. JMP Securities lifted their target price on Axon Enterprise from $430.00 to $500.00 and gave the company a “market outperform” rating in a research note on Thursday, October 31st. Robert W. Baird boosted their target price on Axon Enterprise from $600.00 to $800.00 and gave the company an “outperform” rating in a report on Friday, December 6th. Finally, Needham & Company LLC increased their price target on Axon Enterprise from $525.00 to $600.00 and gave the stock a “buy” rating in a report on Friday, November 8th. One equities research analyst has rated the stock with a hold rating and fourteen have issued a buy rating to the company’s stock. Based on data from MarketBeat, the company has a consensus rating of “Moderate Buy” and an average price target of $504.92.

Axon Enterprise Stock Up 0.3 %

Shares of NASDAQ AXON opened at $607.60 on Thursday. The firm has a 50-day moving average price of $617.26 and a 200 day moving average price of $466.40. Axon Enterprise, Inc. has a 52 week low of $247.04 and a 52 week high of $698.67. The company has a quick ratio of 2.63, a current ratio of 2.96 and a debt-to-equity ratio of 0.32. The stock has a market capitalization of $46.33 billion, a price-to-earnings ratio of 157.00, a price-to-earnings-growth ratio of 6.07 and a beta of 1.04.

Axon Enterprise Company Profile

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.